These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35678779)

  • 1. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis.
    Lui JK; Gillmeyer KR; Sangani RA; Smyth RJ; Gopal DM; Trojanowski MA; Bujor AM; Soylemez Wiener R; LaValley MP; Klings ES
    Arthritis Care Res (Hoboken); 2023 Jul; 75(7):1462-1468. PubMed ID: 35678779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis.
    Yoneda K; Takahashi S; Nakayama K; Iwahashi M; Emoto N; Kumagai S
    Int J Rheum Dis; 2023 Mar; 26(3):493-500. PubMed ID: 36737419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.
    Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG
    Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
    J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension.
    Lui JK; Gillmeyer KR; Sangani RA; Smyth RJ; Gopal DM; Trojanowski MA; Bujor AM; Soylemez Wiener R; LaValley MP; Klings ES
    Lung; 2023 Dec; 201(6):565-569. PubMed ID: 37957388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.
    Colalillo A; Hachulla E; Pellicano C; Smith V; Bergmann C; Riemekasten G; Zanatta E; Henes J; Launay D; Marcoccia A; Gheorghiu AM; Truchetet ME; Iannone F; Simeón Aznar CP; Oliveira S; Vonk M; Del Galdo F; Rosato E;
    Chest; 2024 Oct; 166(4):837-844. PubMed ID: 38849072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.
    Denton CP; Cailes JB; Phillips GD; Wells AU; Black CM; Bois RM
    Br J Rheumatol; 1997 Feb; 36(2):239-43. PubMed ID: 9133938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis.
    Bernstein EJ; Mandl LA; Gordon JK; Spiera RF; Horn EM
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1713-8. PubMed ID: 23740875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension.
    Codullo V; Caporali R; Cuomo G; Ghio S; D'Alto M; Fusetti C; Borgogno E; Montecucco C; Valentini G
    Arthritis Rheum; 2013 Sep; 65(9):2403-11. PubMed ID: 23754201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
    Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S
    Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension.
    Nagel C; Henn P; Ehlken N; D'Andrea A; Blank N; Bossone E; Böttger A; Fiehn C; Fischer C; Lorenz HM; Stöckl F; Grünig E; Egenlauf B
    Arthritis Res Ther; 2015 Jun; 17(1):165. PubMed ID: 26084934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
    Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
    Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort.
    Young A; Moles VM; Jaafar S; Visovatti S; Huang S; Vummidi D; Nagaraja V; McLaughlin V; Khanna D
    Arthritis Rheumatol; 2021 Sep; 73(9):1731-1737. PubMed ID: 33760392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
    Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.
    Gopal DM; Doldt B; Finch K; Simms RW; Farber HW; Gokce N
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1386-94. PubMed ID: 24515598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
    Hinchcliff M; Fischer A; Schiopu E; Steen VD;
    J Rheumatol; 2011 Oct; 38(10):2172-9. PubMed ID: 21844142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China.
    Hong C; Chen R; Hu L; Liu H; Lu J; Zhuang C; Guo W; Wu X; Lin J; Sun X; Tang H; Wang Z; Zhang N; Zheng Z
    Clin Respir J; 2023 Jun; 17(6):536-547. PubMed ID: 37141914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.